SCHEMBL3371209

SCHEMBL3371209

C/C=C\c1ccc(OC)c(O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.73
APP P05067 3/20 0.71
TUBB1 Q9H4B7 9/20 0.69
TUBB4A P04350 3/20 0.67
TUBB P07437 3/20 0.67
TUBA3C P0DPH7 3/20 0.67
TUBA1B P68363 3/20 0.67
TUBA4A P68366 3/20 0.67
TUBB4B P68371 3/20 0.67
TUBB3 Q13509 3/20 0.67
TUBB2A Q13885 3/20 0.67
TUBB8 Q3ZCM7 3/20 0.67
TUBA3E Q6PEY2 3/20 0.67
TUBA1A Q71U36 3/20 0.67
TUBA1C Q9BQE3 3/20 0.67
TUBB6 Q9BUF5 3/20 0.67
TUBB2B Q9BVA1 3/20 0.67
ALOX5 P09917 1/20 0.67
NQO1 P15559 1/20 0.67
NQO2 P16083 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29639723 1.00 TYR (0.73) TYRAPPTUBB1TUBB4ATUBB
SCHEMBL1682661 1.00 TYR (0.73) TYRAPPTUBB1TUBB4ATUBB
SCHEMBL1682625 1.00 TYR (0.73) TYRAPPTUBB1TUBB4ATUBB
Butane SCHEMBL27586084 0.93 TYR (0.65) TYRAPPTUBB1TUBB4ATUBB
SCHEMBL21798687 0.85 TUBB1 (0.81) APPTUBB1TUBB4ATUBBTUBA3C
Cis/Trans-Isoeugenol SCHEMBL2463283 0.85 TYR (1.00) TYRAPPALOX5ABCB1ALDH1A1
Cis/Trans-Isoeugenol SCHEMBL57987 0.85 TYR (1.00) TYRAPPALOX5ABCB1ALDH1A1
Isoeugenol SCHEMBL29369838 0.85 TYR (1.00) TYRAPPALOX5ABCB1ALDH1A1
Isoeugenol SCHEMBL2463281 0.85 TYR (1.00) TYRAPPALOX5ABCB1ALDH1A1
Isoeugenol SCHEMBL300766 0.85 TYR (1.00) TYRAPPALOX5ABCB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051551-A1 IMPROVED POLYMER COMPOSITES WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2025-02-13 US claimed
US-20190177862-A1 HYDROGEN UTILIZATION AND CARBON RECOVERY COORSTEK, INC. 2019-06-13 US claimed
EP-3039099-B1 METHOD FOR UPGRADING BIOMASS MATERIAL COORSTEK INC (US) 2019-06-12 EP claimed
EP-3039099-A1 HYDROGEN UTILIZATION AND CARBON RECOVERY Ceramatec, Inc (US) 2016-07-06 EP claimed
WO-2015031889-A1 HYDROGEN UTILIZATION AND CARBON RECOVERY CERAMATEC, INC. (US) 2015-03-05 WO claimed
US-20150060296-A1 Hydrogen Utilization and Carbon Recovery COORSTEK, INC. 2015-03-05 US claimed
WO-2013091451-A1 IMPROVER FOR VISBREAKING AND PROCESS FOR CO-VISBREAKING TO COAL TAR OR BIO-OIL CONTAINING THE SAME AND HEAVY OIL SHENHUA GROUP CORPORATION LIMITED (CN) 2013-06-27 WO claimed
EP-1124671-B1 BIO-OIL PRESERVATIVES ENSYN TECHNOLOGIES INC (CA) 2007-07-25 EP claimed
US-20250051551-A1 IMPROVED POLYMER COMPOSITES WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2025-02-13 US disclosed
US-12163004-B2 Polymer composites WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-12-10 US disclosed
US-20240355451-A1 METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY NESTLE SA (CH) 2024-10-24 US disclosed
US-20240216296-A1 POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY EPICEUTICAL LABS LLC 2024-07-04 US disclosed
EP-4391834-A1 METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY Société des Produits Nestlé S.A. (CH) 2024-07-03 EP disclosed
US-20240101791-A1 POLYMER COMPOSITES WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-03-28 US disclosed
US-20150060296-A1 Hydrogen Utilization and Carbon Recovery COORSTEK, INC. 2015-03-05 US disclosed
WO-2013091451-A1 IMPROVER FOR VISBREAKING AND PROCESS FOR CO-VISBREAKING TO COAL TAR OR BIO-OIL CONTAINING THE SAME AND HEAVY OIL SHENHUA GROUP CORPORATION LIMITED (CN) 2013-06-27 WO disclosed
EP-0955994-B1 FRAGRANCE DELIVERY SYSTEMS FOR PERSONAL CARE ARTICLES PROCTER & GAMBLE (US) 2010-11-03 EP disclosed
EP-0229033-B1 THIOL/ENE COMPOSITIONS LOCTITE (IRELAND) Ltd. (IE) 1993-03-03 EP disclosed
US-5021512-A Curable LOCTITE (IRELAND) LTD. (IE) 1991-06-04 US disclosed
EP-0229033-A2 Thiol/ene compositions LOCTITE (IRELAND) Ltd. (IE) 1987-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240216296-A1 POLYPHENOL COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY FABP2, HDLBP, FABP1 TYR 894/4885APP 2284/4885TUBB1 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.